Jialiang Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jialiang Lin has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Weishi Li
Department of Orthopaedics, Peking University Third Hospital, Beijing 100191, China
8 shared publications - Longjie Wang
Department of Orthopaedics, Peking University Third Hospital, Beijing, China
3 shared publications - Shuai Jiang
Orthopaedic Department, Peking University Third Hospital, No. 49 North Garden Road, Beijing, 100191, China.
2 shared publications - Yudong Zhao
Department of Orthopaedics, Peking University Third Hospital, Beijing 100191, China
2 shared publications - Chuiguo Sun
Peking University Third Hospital, Department of Orthopaedics, China
1 shared publication ChunXia Zhao
Department of Orthopaedics, Peking University Third Hospital, Beijing, China
1 shared publication
Latest Publications
- 14 September 2026
- Published by Wolters Kluwer Health in Spine
The State of Spine Surgery in China
Was not provided for this article.
- 14 September 2026
- Published by Wolters Kluwer Health in Spine
The State of Spine Surgery in China
Was not provided for this article.
- 6 August 2026
- Published by Wolters Kluwer Health in Spine
Development and Initial Validation of Patient-reported Lumbar Surgery Quality of Life (LSQoL)
Study Design.: A mixed-methods study. Objective.: To develop and perform the initial validation of the Lumbar Surgery Quality of Life (LSQoL), a multidimensional patient-reported outcome measure for patients with lumbar degenerative diseases. Summary of background data.: Patient-reported outcome measures (PROMs) are widely used to evaluate outcomes in lumbar degenerative diseases but are often applied in combination, with each instrument capturing only specific aspects of patient status. Consequently, improvement in traditional measures such as the Oswestry Disability Index (ODI) does not always correspond to patient-perceived recovery or satisfaction, highlighting the need for multidimensional tools that better reflect patient experience. Methods.: The LSQoL was developed using a multistage mixed-method approach, including literature review, patient interviews, expert consensus through the Delphi method, and weighting via the Analytic Hierarchy Process (AHP). The instrument was validated in 1,996 patients with lumbar degenerative diseases. Internal consistency, test–retest reliability, construct validity, and correlations with established PROMs and patient-reported recovery and satisfaction were evaluated. Results.: The LSQoL consists of 21 items across five dimensions: pain, neurological function, activities of daily living, emotional status, and working ability. Internal consistency was acceptable to good (Cronbach’s α: 0.744–0.805), and test–retest reliability was strong (ICC: 0.759–0.906). Factor analyses supported a stable multidimensional structure. The LSQoL demonstrated moderate correlations with established PROMs and stronger correlations with patient-reported recovery and satisfaction. Conclusion.: The LSQoL is a reliable and valid PROM that provides a comprehensive assessment of quality of life in patients with lumbar degenerative diseases. It is suitable for evaluating patient-reported outcomes both before and after lumbar surgery.
- 6 August 2026
- Published by Wolters Kluwer Health in Spine
Development and Initial Validation of Patient-reported Lumbar Surgery Quality of Life (LSQoL)
Study Design.: A mixed-methods study. Objective.: To develop and perform the initial validation of the Lumbar Surgery Quality of Life (LSQoL), a multidimensional patient-reported outcome measure for patients with lumbar degenerative diseases. Summary of background data.: Patient-reported outcome measures (PROMs) are widely used to evaluate outcomes in lumbar degenerative diseases but are often applied in combination, with each instrument capturing only specific aspects of patient status. Consequently, improvement in traditional measures such as the Oswestry Disability Index (ODI) does not always correspond to patient-perceived recovery or satisfaction, highlighting the need for multidimensional tools that better reflect patient experience. Methods.: The LSQoL was developed using a multistage mixed-method approach, including literature review, patient interviews, expert consensus through the Delphi method, and weighting via the Analytic Hierarchy Process (AHP). The instrument was validated in 1,996 patients with lumbar degenerative diseases. Internal consistency, test–retest reliability, construct validity, and correlations with established PROMs and patient-reported recovery and satisfaction were evaluated. Results.: The LSQoL consists of 21 items across five dimensions: pain, neurological function, activities of daily living, emotional status, and working ability. Internal consistency was acceptable to good (Cronbach’s α: 0.744–0.805), and test–retest reliability was strong (ICC: 0.759–0.906). Factor analyses supported a stable multidimensional structure. The LSQoL demonstrated moderate correlations with established PROMs and stronger correlations with patient-reported recovery and satisfaction. Conclusion.: The LSQoL is a reliable and valid PROM that provides a comprehensive assessment of quality of life in patients with lumbar degenerative diseases. It is suitable for evaluating patient-reported outcomes both before and after lumbar surgery.
- Open Access
- 23 December 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 56, 101013
A clinico-molecular classification scheme for ossification of ligamentum flavum: Based on 1034 cases
- 23 December 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 56, 101013
Open AccessA clinico-molecular classification scheme for ossification of ligamentum flavum: Based on 1034 cases
- Open Access
- 12 June 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (6) , 713
Intervertebral Disc Progenitors: Lessons Learned from Single-Cell RNA Sequencing and the Role in Intervertebral Disc Regeneration
The tremendous personal and economic burden worldwide caused by low back pain (LBP) has been surging in recent years. While intervertebral disc degeneration (IVDD) is the leading cause of LBP and vast efforts have been made to develop effective therapies, this problem is far from being resolved, as most treatments, such as painkillers and surgeries, mainly focus on relieving the symptoms rather than reversing the cause of IVDD. However, as stem/progenitor cells possess the potential to regenerate IVD, a deeper understanding of the early development and role of these cells could help to improve the effectiveness of stem/progenitor cell therapy in treating LBP. Single-cell RNA sequencing results provide fresh insights into the heterogeneity and development patterns of IVD progenitors; additionally, we compare mesenchymal stromal cells and IVD progenitors to provide a clearer view of the optimal cell source proposed for IVD regeneration.
- 12 June 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (6) , 713
Open AccessIntervertebral Disc Progenitors: Lessons Learned from Single-Cell RNA Sequencing and the Role in Intervertebral Disc Regeneration
The tremendous personal and economic burden worldwide caused by low back pain (LBP) has been surging in recent years. While intervertebral disc degeneration (IVDD) is the leading cause of LBP and vast efforts have been made to develop effective therapies, this problem is far from being resolved, as most treatments, such as painkillers and surgeries, mainly focus on relieving the symptoms rather than reversing the cause of IVDD. However, as stem/progenitor cells possess the potential to regenerate IVD, a deeper understanding of the early development and role of these cells could help to improve the effectiveness of stem/progenitor cell therapy in treating LBP. Single-cell RNA sequencing results provide fresh insights into the heterogeneity and development patterns of IVD progenitors; additionally, we compare mesenchymal stromal cells and IVD progenitors to provide a clearer view of the optimal cell source proposed for IVD regeneration.
- Open Access
- 30 May 2023
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 10, 1213380
Editorial: Oxidative stress in degenerative bone and joint diseases: novel molecular mechanisms and therapeutic potential
Editorial: Oxidative stress in degenerative bone and joint diseases: novel molecular mechanisms and therapeutic potential
- 30 May 2023
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 10, 1213380
Open AccessEditorial: Oxidative stress in degenerative bone and joint diseases: novel molecular mechanisms and therapeutic potential
Editorial: Oxidative stress in degenerative bone and joint diseases: novel molecular mechanisms and therapeutic potential
- Open Access
- 3 October 2022
- Published by Wiley in Stem Cells International
- Vol. 2022, 1-14
Mesenchymal Stem Cells May Alleviate the Intervertebral Disc Degeneration by Reducing the Oxidative Stress in Nucleus Pulposus Cells
Background. Stem cell therapy is a promising therapeutic modality for intervertebral disc degeneration (IDD). Oxidative stress is a vital contributor to the IDD; however, the definite role of oxidative stress in stem cell therapy for IDD remains obscure. The aim of this study was to determine the vital role of oxidative stress-related differentially expressed genes (OSRDEGs) in degenerative NPCs cocultured with mesenchymal stem cells (MSCs). Methods. A series of bioinformatic methods were used to calculate the oxidative stress score and autophagy score, identify the OSRDEGs, conduct the function enrichment analysis and protein-protein interaction (PPI) analysis, build the relevant competing endogenous RNA (ceRNA) regulatory networks, and explore the potential association between oxidative stress and autophagy in degenerative NPCs cocultured with MSCs. Results. There was a significantly different oxidative stress score between NPC/MSC samples and NPC samples ( ). Forty-one OSRDEGs were selected for the function enrichment and PPI analyses. Ten hub OSRDEGs were obtained according to the PPI score, including JUN, CAT, PTGS2, TLR4, FOS, APOE, EDN1, TXNRD1, LRRK2, and KLF2. The ceRNA regulatory network, which contained 17 DElncRNAs, 240 miRNAs, and 10 hub OSRDEGs, was constructed. Moreover, a significant relationship between the oxidative stress score and autophagy score was observed ( ), and 125 significantly related gene pairs were obtained ( , ). Conclusion. Stem cell therapy might repair the degenerative IVD via reducing the oxidative stress through the ceRNA regulatory work and restoration of autophagy in degenerative NPCs. This research could provide new insights into the mechanism research of stem cell therapy for IDD and potential therapeutic targets in the IDD treatment.
- 3 October 2022
- Published by Wiley in Stem Cells International
- Vol. 2022, 1-14
Open AccessMesenchymal Stem Cells May Alleviate the Intervertebral Disc Degeneration by Reducing the Oxidative Stress in Nucleus Pulposus Cells
Background. Stem cell therapy is a promising therapeutic modality for intervertebral disc degeneration (IDD). Oxidative stress is a vital contributor to the IDD; however, the definite role of oxidative stress in stem cell therapy for IDD remains obscure. The aim of this study was to determine the vital role of oxidative stress-related differentially expressed genes (OSRDEGs) in degenerative NPCs cocultured with mesenchymal stem cells (MSCs). Methods. A series of bioinformatic methods were used to calculate the oxidative stress score and autophagy score, identify the OSRDEGs, conduct the function enrichment analysis and protein-protein interaction (PPI) analysis, build the relevant competing endogenous RNA (ceRNA) regulatory networks, and explore the potential association between oxidative stress and autophagy in degenerative NPCs cocultured with MSCs. Results. There was a significantly different oxidative stress score between NPC/MSC samples and NPC samples ( ). Forty-one OSRDEGs were selected for the function enrichment and PPI analyses. Ten hub OSRDEGs were obtained according to the PPI score, including JUN, CAT, PTGS2, TLR4, FOS, APOE, EDN1, TXNRD1, LRRK2, and KLF2. The ceRNA regulatory network, which contained 17 DElncRNAs, 240 miRNAs, and 10 hub OSRDEGs, was constructed. Moreover, a significant relationship between the oxidative stress score and autophagy score was observed ( ), and 125 significantly related gene pairs were obtained ( , ). Conclusion. Stem cell therapy might repair the degenerative IVD via reducing the oxidative stress through the ceRNA regulatory work and restoration of autophagy in degenerative NPCs. This research could provide new insights into the mechanism research of stem cell therapy for IDD and potential therapeutic targets in the IDD treatment.
- Open Access
- 2 February 2022
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-12
Herbal Formula Modified Bu-Shen-Huo-Xue Decoction Attenuates Intervertebral Disc Degeneration via Regulating Inflammation and Oxidative Stress
Objective. This study aims to clarify the potential mechanism of modified Bu-Shen-Huo-Xue decoction (MBSHXD) in treating intervertebral disc degeneration (IDD) with methods of network pharmacology and molecular docking. Methods. An MBSHXD and IDD-related common target gene set was established through TCMSP, UniProt, and two disease gene databases. GO and KEGG enrichment analysis and protein-protein interaction (PPI) networks were performed through the R platform and STRING to discover the potential mechanism. Molecular docking between the active ingredients and the core genes is used to calculate the binding energy. Results. A total of 147 active ingredients and 79 common genes (including 10 core genes, TNF, VEGFA, IL6, MAPK3, AKT1, MAPK8, TP53, JUN, MMP9, and CXCL8) were identified. The results of GO and KEGG enrichment analysis showed that MBSHXD plays an essential role in regulating inflammation and oxidative stress. The meaningful pathways are the AGE-RAGE signaling pathway in diabetic complications, the IL-17 signaling pathway, the TNF signaling pathway, the PI3K-Akt signaling pathway, the MAPK signaling pathway, and apoptosis. In addition, the PPI network and molecular docking further demonstrated the roles that nine bioactive ingredients of MBSHXD play in IDD treatment through their interference with core target proteins. Conclusion. This study reveals that MBSHXD has the characteristics of a multi-component, multi-target, and multi-pathway in the treatment of IDD by regulating inflammation and oxidative stress, and network pharmacology may provide a feasible method to verify the molecular mechanism of MBSHXD for IDD by combining with molecular docking.
- 2 February 2022
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-12
Open AccessHerbal Formula Modified Bu-Shen-Huo-Xue Decoction Attenuates Intervertebral Disc Degeneration via Regulating Inflammation and Oxidative Stress
Objective. This study aims to clarify the potential mechanism of modified Bu-Shen-Huo-Xue decoction (MBSHXD) in treating intervertebral disc degeneration (IDD) with methods of network pharmacology and molecular docking. Methods. An MBSHXD and IDD-related common target gene set was established through TCMSP, UniProt, and two disease gene databases. GO and KEGG enrichment analysis and protein-protein interaction (PPI) networks were performed through the R platform and STRING to discover the potential mechanism. Molecular docking between the active ingredients and the core genes is used to calculate the binding energy. Results. A total of 147 active ingredients and 79 common genes (including 10 core genes, TNF, VEGFA, IL6, MAPK3, AKT1, MAPK8, TP53, JUN, MMP9, and CXCL8) were identified. The results of GO and KEGG enrichment analysis showed that MBSHXD plays an essential role in regulating inflammation and oxidative stress. The meaningful pathways are the AGE-RAGE signaling pathway in diabetic complications, the IL-17 signaling pathway, the TNF signaling pathway, the PI3K-Akt signaling pathway, the MAPK signaling pathway, and apoptosis. In addition, the PPI network and molecular docking further demonstrated the roles that nine bioactive ingredients of MBSHXD play in IDD treatment through their interference with core target proteins. Conclusion. This study reveals that MBSHXD has the characteristics of a multi-component, multi-target, and multi-pathway in the treatment of IDD by regulating inflammation and oxidative stress, and network pharmacology may provide a feasible method to verify the molecular mechanism of MBSHXD for IDD by combining with molecular docking.
- Open Access
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Pharmacological Mechanism of Danggui‐Sini Formula for Intervertebral Disc Degeneration: A Network Pharmacology Study
Background. Intervertebral disc degeneration (IVDD) is the most significant cause of low back pain, the sixth‐largest disease burden globally, and the leading cause of disability. This study is aimed at investigating the molecular biological mechanism of Danggui‐Sini formula (DSF) mediated IVDD treatment. Methods. A potential gene set for DSF treatment of IVDD was identified through TCMSP, UniProt, and five disease gene databases. A protein interaction network of common targets between DSF and IVDD was established by using the STRING database. GO and KEGG enrichment analyses were performed using the R platform to discover the potential mechanism. Moreover, AutoDock Vina was used to verify molecular docking and calculate the binding energy. Results. A total of 119 active ingredients and 136 common genes were identified, including 10 core genes (AKT1, IL6, ALB, TNF, VEGFA, TP53, MAPK3, CASP3, JUN, and EGF). Enrichment analysis results showed that the therapeutic targets of DSF for diseases mainly focused on the AGE‐RAGE signaling pathway involved in diabetic complications, IL‐17 signaling pathway, TNF signaling pathway, Toll‐like receptor signaling pathway, apoptosis, cellular senescence, PI3K‐Akt signaling pathway, and FoxO signaling pathway. These biological processes are induced mainly in response to oxidative stress and reactive oxygen species and the regulation of apoptotic signaling pathways. Molecular docking showed that there was a stable affinity between the core genes and the key components. Conclusions. The combination of network pharmacology and molecular docking provides a practical way to analyze the molecular biological mechanism of DSF‐mediated IVDD treatment, which confirms the “multicomponent, multitarget and multipathway” characteristics of DSF and provides an essential theoretical basis for clinical practice.
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Open AccessPharmacological Mechanism of Danggui‐Sini Formula for Intervertebral Disc Degeneration: A Network Pharmacology Study
Background. Intervertebral disc degeneration (IVDD) is the most significant cause of low back pain, the sixth‐largest disease burden globally, and the leading cause of disability. This study is aimed at investigating the molecular biological mechanism of Danggui‐Sini formula (DSF) mediated IVDD treatment. Methods. A potential gene set for DSF treatment of IVDD was identified through TCMSP, UniProt, and five disease gene databases. A protein interaction network of common targets between DSF and IVDD was established by using the STRING database. GO and KEGG enrichment analyses were performed using the R platform to discover the potential mechanism. Moreover, AutoDock Vina was used to verify molecular docking and calculate the binding energy. Results. A total of 119 active ingredients and 136 common genes were identified, including 10 core genes (AKT1, IL6, ALB, TNF, VEGFA, TP53, MAPK3, CASP3, JUN, and EGF). Enrichment analysis results showed that the therapeutic targets of DSF for diseases mainly focused on the AGE‐RAGE signaling pathway involved in diabetic complications, IL‐17 signaling pathway, TNF signaling pathway, Toll‐like receptor signaling pathway, apoptosis, cellular senescence, PI3K‐Akt signaling pathway, and FoxO signaling pathway. These biological processes are induced mainly in response to oxidative stress and reactive oxygen species and the regulation of apoptotic signaling pathways. Molecular docking showed that there was a stable affinity between the core genes and the key components. Conclusions. The combination of network pharmacology and molecular docking provides a practical way to analyze the molecular biological mechanism of DSF‐mediated IVDD treatment, which confirms the “multicomponent, multitarget and multipathway” characteristics of DSF and provides an essential theoretical basis for clinical practice.